Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human GASP-1/WFIKKN2 Antibody, R&D Systems™

Mouse Monoclonal Antibody
Supplier: R&D Systems MAB20702SP
This item is not returnable.
View return policy
Description
GASP-1/WFIKKN2 Monoclonal specifically detects GASP-1/WFIKKN2 in Human samples. It is validated for ELISA Capture (Matched Antibody Pair).Specifications
GASP-1/WFIKKN2 | |
Monoclonal | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
GASP1, GASP-1, Growth and differentiation factor-associated serum protein 1, hGASP-1, WAP, follistatin, immunoglobulin, kunitz and NTR domain-containing-relatedprotein, WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2, WAP, FS, Ig, two KU and NTR module related protein, WAP, kazal, immunoglobulin, kunitz and NTR domain-containing protein 2, WFIKKN2, WFIKKN-related protein, WFIKKNRP, WFIKKNRPmultivalent protease inhibitor protein | |
Mouse | |
Protein A or G purified from hybridoma culture supernatant | |
RUO | |
124857 | |
Reconstitute at 0.5 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
IgG2b |
ELISA | |
288504 | |
ELISA Capture (Matched Antibody Pair) 2-8 ug/mL | |
Q8TEU8 | |
WFIKKN2 | |
Mouse myeloma cell line NS0-derived recombinant human GASP-1/WFIKKN2 Leu35-His576 Accession # Q8TEU8 | |
25 μg | |
Primary | |
Detect human GASP-1/WFIKKN2 in ELISAs. | |
Human | |
Purified |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction